首页> 外文期刊>Frontiers in Neuropharmacology >Neuroprotective and Angiogenesis Effects of Levetiracetam Following Ischemic Stroke in Rats
【24h】

Neuroprotective and Angiogenesis Effects of Levetiracetam Following Ischemic Stroke in Rats

机译:Levetiracetam在大鼠缺血性脑卒中后Nevetiracetam的神经保护和血管生成效应

获取原文
       

摘要

The present study explored whether levetiracetam (LEV) could protect against experimental brain ischemia and enhance angiogenesis in rats, and investigated the potential mechanisms in vivo and in vitro. Methods: The middle cerebral artery was occluded for 60 min to induce middle cerebral artery occlusion (MCAO). The Morris water maze was used to measure cognitive ability. The rotation test was used to assess locomotor function. T2-weighted MRI was used to assess infarct volume. The neuronal cells in the cortex area were stained with cresyl purple. The anti-inflammatory effects of LEV on microglia were observed by immunohistochemistry. Enzyme-linked immunosorbent assays (ELISA) were used to measure the production of pro-inflammatory cytokines. Western blotting was used to detect the levels of heat shock protein 70 (HSP70), vascular endothelial growth factor (VEGF), and hypoxia-inducible factor-1α (HIF-1α) in extracts from the ischemic cortex. Flow cytometry was used to observe the effect of LEV on neuronal cell apoptosis. Results: LEV treatment significantly increased the density of the surviving neurons in the cerebral cortex and reduced the infarct size (17.8 ± 3.3% vs. 12.9 ± 1.4%, p < 0.01) after MCAO. Concurrently, the time required to reach the platform for LEV-treated rats was shorter than that in the saline group on day 11 after MCAO (p < 0.01). LEV treatment prolonged the rotarod retention time on day 14 after MCAO (84.5 ± 6.7 s vs. 59.1 ± 6.2 s on day 14 compared with the saline-treated groups, p < 0.01). It also suppressed the activation of microglia and inhibited TNF-α and Il-1β in the ischemic brain (135.6 ± 5.2 pg/ml vs. 255.3 ± 12.5 pg/ml, 18.5 ± 1.3 pg/ml vs. 38.9 ± 2.3 pg/ml on day 14 compared with the saline-treated groups, p < 0.01). LEV treatment resulted in a significant increase in HIF-1α, VEGF, and HSP70 levels in extracts from the ischemic cerebral cortex. At the same time, LEV reduced neuronal cell cytotoxicity and apoptosis induced by an ischemic stroke (p < 0.01). Conclusion: LEV treatment promoted angiogenesis and functional recovery after cerebral ischemia in rats. These effects seem to be mediated through anti-inflammatory and antiapoptotic activities, as well as inducing the expression of HSP70, VEGF, and HIF-1α.
机译:本研究探讨了Levetiracetam(Lev)是否可以防止实验性脑缺血并增强大鼠血管生成,并研究体内和体外潜在机制。方法:堵塞中间脑动脉60分钟以诱导中脑动脉闭塞(MCAO)。 Morris水迷宫用于测量认知能力。旋转试验用于评估运动功能。 T2加权MRI用于评估梗塞体积。皮质区域中的神经元细胞用烯基紫色染色。免疫组织化学观察到对小胶质细胞的抗炎作用。使用酶联免疫吸附试验(ELISA)来测量促炎细胞因子的产生。蛋白质印迹用于检测来自缺血性皮层的提取物中的热休克蛋白70(HSP70),血管内皮生长因子(VEGF)和缺氧诱导因子-1α(HIF-1α)的水平。流式细胞仪用于观察LEV对神经元细胞凋亡的影响。结果:LEV治疗显着增加了脑皮层中存活神经元的密度,并降低了MCAO后的梗塞尺寸(17.8±3.3%,P <0.01)。同时,在MCAO后第11天在第11天(P <0.01)时,达到患有lev处理的大鼠平台所需的时间短于盐水中的时间短。 LEV处理在MCAO后第14天(第14天在第14天与盐水处理的组相比,P <0.01)延长了第14天(84.5±6.7s与59.1±6.2秒)。它还抑制了缺血性脑中的微胶质细胞的激活并抑制了TNF-α和IL-1β(135.6±5.2 pg / ml与255.3±12.5 pg / ml,18.5±1.3 pg / ml与38.9±2.3 pg / ml在第14天与盐水处理组相比,P <0.01)。 LEV治疗导致来自缺血性脑皮质的提取物中的HIF-1α,VEGF和HSP70水平显着增加。同时,Lev降低了由缺血性卒中引起的神经元细胞细胞毒性和凋亡(P <0.01)。结论:LEV治疗在大鼠脑缺血后促进血管生成和功能恢复。这些效果似乎是通过抗炎和抗污染物活性介导的,以及诱导HSP70,VEGF和HIF-1α的表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号